MiR-34a downregulates the expressions of more than 30 oncogenes such as BCL2, CDK4/6, CD44, NOTCH1, MYC, MET, and PDGFR-α [126], and genes involved in tumor immune escape including PD-L1 and DGKζ [127,128,129]. This evidence concerns the gene CD274 and neoplasm.